Inhibition of RANKL/mCSF-induced osteoclast differentiation in C57BL/6 mouse BMMC assessed as reduction in TRAP-positive multinucleated cells at 30 uM by microscopic method relative to control
Inhibition of RANKL/mCSF-induced osteoclast differentiation in C57BL/6 mouse BMMC assessed as reduction in TRAP-positive multinucleated cells by microscopic method
Inhibition of RANKL/RANK protein-protein interaction in mouse RAW264.7 cells assessed as reduction in RANKL-stimulated NF-kB signaling pathway activation by measuring decrease in IkBalpha phosphorylation after 2 hrs by immunoblot assay
Drug metabolism assessed as alpha-chymotrypsin (unknown origin)-mediated compound degradation by measuring parent compound remaining after 8 hrs by HPLC analysis
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse distal femur bone at 20 mg/kg/day, ip after 6 weeks by H and E staining based microscopic method
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse assessed as reduction in TRAP-positive multinucleated cells in distal femur bone at 20 mg/kg/day, ip after 6 weeks by microscopic method
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse distal femur bone assessed as increase in bone volume expressed per unit total volume at 20 mg/kg/day, ip after 6 weeks by micro-CT analysis
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse distal femur bone assessed as increase in bone surface area expressed per unit total volume at 20 mg/kg/day, ip after 6 weeks by micro-CT analysis
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse distal femur bone assessed as increase in trabecular number at 20 mg/kg/day, ip after 6 weeks by micro-CT analysis
Inhibition of ovariectomy-induced trabecular bone loss in C57BL/6 mouse distal femur bone assessed as increase in bone mineral density at 20 mg/kg/day, ip after 6 weeks by micro-CT analysis
Inhibition of osteoclastogenesis in ovariectomized C57BL/6 mouse assessed as decrease in serum TNFalpha level at 20 mg/kg/day, ip after 6 weeks by ELISA
Inhibition of osteoclastogenesis in ovariectomized C57BL/6 mouse assessed as decrease in serum TRAcp5B level at 20 mg/kg/day, ip after 6 weeks by ELISA